These genetic mutations can deregulate the mitogen-activated protein kinase (MAPK) and phosphatidylinositol-3 kinase (PI3K)/AKT signalling pathways which are crucial to the pathogenesis of thyroid cancer [11]. The gene discussed is AKT1; the disease is thyroid gland carcinoma.